Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and telmisartan

thiazoles has been researched along with telmisartan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J1
Huang, M; Song, H; Wang, K; Xie, L; Xu, C; Xu, S1
Behl, G; Boakye, CH; Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M1

Other Studies

3 other study(ies) available for thiazoles and telmisartan

ArticleYear
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5

    Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain

2004
Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway.
    International journal of molecular medicine, 2014, Volume: 34, Issue:3

    Topics: Benzimidazoles; Benzoates; Chemokine CCL2; Gene Expression Regulation; HL-60 Cells; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Inflammation Mediators; NF-kappa B; PPAR delta; Protein Transport; RNA, Messenger; Signal Transduction; Telmisartan; Thiazoles; Vascular Cell Adhesion Molecule-1

2014
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.
    Nanomedicine (London, England), 2016, Volume: 11, Issue:11

    Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Coumarins; Docetaxel; Female; Heterografts; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Taxoids; Telmisartan; Thiazoles; Tumor Burden

2016